IO Biotech reports annual meeting results
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
IO Biotech Inc (IOBT)
IO Biotech Inc stock price live, this page displays NASDAQ IOBT stock exchange data. View the IOBT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the IO Biotech Inc real time stock price chart below.
What Is the IO Biotech Inc Stock Price Today?
The IO Biotech Inc stock price today is 2.137.
What Is the Stock Symbol for IO Biotech Inc?
The stock symbol for IO Biotech Inc is ""IOBT.""
What Stock Exchange Does IO Biotech Inc Trade On?
IO Biotech Inc is listed and trades on the NASDAQ stock exchange.
Is IO Biotech Inc a Good Stock to Buy?
Determining whether IO Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IOBT quote. (ISIN: US4497781090)
What Is the IO Biotech Inc Stock Price Today?
The IO Biotech Inc stock price today is 2.137.
What Is the Stock Symbol for IO Biotech Inc?
The stock symbol for IO Biotech Inc is ""IOBT.""
What Stock Exchange Does IO Biotech Inc Trade On?
IO Biotech Inc is listed and trades on the NASDAQ stock exchange.
Is IO Biotech Inc a Good Stock to Buy?
Determining whether IO Biotech Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IOBT quote. (ISIN: US4497781090)
NASDAQ
Currency in USD
2.137
-0.083(-3.73%)
Real-time Data·
Fair Value
An estimate of a IO Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.061
2.200
52 wk Range
0.660
2.477
IOBT Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 4 days
More Info
Fair Value
An estimate of a IO Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.0612.200
52 wk Range
0.6602.477
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IOBT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a IO Biotech's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
9.500
Upside
+344.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
IO Biotech Inc Company Profile
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company’s lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to treat lung, head and neck, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide to target T cells that recognize epitopes derived from Arginase 1, which is an immunoregulatory enzyme highly expressed in difficult-to-treat tumors associated with high levels of myeloid-derived suppressor cells, including renal cell carcinoma, head and neck, breast, pancreatic, ovarian, colorectal, and prostate cancers. In addition, the company develops IO170, a TGFß1 vaccine for the treatment of solid tumors. IO Biotech, Inc. was incorporated in 2014 and is based in Copenhagen, Denmark.
Compare IOBT to Peers and Sector
Metrics to compare | IOBT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIOBTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −1.9x | −0.5x | |
PEG Ratio | −0.14 | −0.02 | 0.00 | |
Price/Book | 5.3x | 2.2x | 2.6x | |
Price / LTM Sales | - | 10.0x | 3.3x | |
Upside (Analyst Target) | 305.4% | 249.3% | 45.1% | |
Fair Value Upside | Unlock | 12.2% | 7.4% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 9.500
(+344.55% Upside)
Earnings
Latest Release
May 14, 2025
EPS / Forecast
-0.34 / -0.31
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does IO Biotech Trade On?
IO Biotech is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for IO Biotech?
The stock symbol for IO Biotech is "IOBT."
What Is the IO Biotech Market Cap?
As of today, IO Biotech market cap is 146.26M.
What Is IO Biotech's Earnings Per Share (TTM)?
The IO Biotech EPS (TTM) is -1.49.
When Is the Next IO Biotech Earnings Date?
IO Biotech will release its next earnings report on 07 Aug 2025.
From a Technical Analysis Perspective, Is IOBT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has IO Biotech Stock Split?
IO Biotech has split 0 times.
How Many Employees Does IO Biotech Have?
IO Biotech has 79 employees.
What is the current trading status of IO Biotech (IOBT)?
As of 04 Aug 2025, IO Biotech (IOBT) is trading at a price of 2.14, with a previous close of 2.22. The stock has fluctuated within a day range of 2.06 to 2.20, while its 52-week range spans from 0.66 to 2.48.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.